- Presentations
- 2
- Markets
- 1
Ruxience is a brand of Rituximab marketed by Pfizer Laboratories, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Rituximab
- Brand owner
- Pfizer Laboratories
- Registered in
- United States
- Strengths and forms
- 100 mg/10 mL injection, 500 mg/50 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Ruxience 100 mg/10 mL injectionIntravenous Cold chain | Pfizer Laboratories | US FDA | Available on request |
| Ruxience 500 mg/50 mL injectionIntravenous Cold chain | Pfizer Laboratories | US FDA | Available on request |
Equivalent brands
Other brands of Rituximab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Ruxience
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.